102 Impact of Home Testing on INR Control and Adverse Events in Black Patients on Warfarin for Atrial Fibrillation or Venous Thromboembolsim
Introduction: Black patients on warfarin have higher rates of stroke, major bleeding, and death compared to White patients. Suboptimal warfarin control, reflected by lower time in therapeutic range (TTR), may contribute to these disparities. Home INR testing has shown mixed results in improving TTR and reducing adverse events (AEs), with limited evidence on its impact in Black patients. Our objective was to compare INR control and AEs between Black home-testers and non-home testers on warfarin for atrial fibrillation (AF) or venous thromboembolism (VTE).
Authors
- Geoffrey D. Barnes (ORCID: https://orcid.org/0000-0002-6532-8440)
- Mona A. Ali (ORCID: https://orcid.org/0000-0003-2416-6702)
- Xiaowen Kong (ORCID: https://orcid.org/0000-0003-4548-3600)
- Tina Alexandris-Souphis
- James B. Froehlich (ORCID: https://orcid.org/0000-0003-2327-8235)
- Noelle Ryan (ORCID: https://orcid.org/0000-0002-8541-3298)
- Beverly Stallings
- Scott S. Kaatz (ORCID: https://orcid.org/0000-0002-3080-3328)
- Brian Haymart
- Gregory D Krol
- Stacy Ellsworth
- Brindha Rajakumar
- Amy DeLellis
Institutions
- University of Michigan (US)
- Henry Ford Hospital (US)
- Michigan Medicine (US)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102788
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00